4.7 Article

MTOR gene variants are associated with severe COVID-19 outcomes: A multicenter study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Allergy

T-Cell Immune Responses and Immunological Factors Associated with Coronavirus Disease 2019 Progression as Predictors for the Severity of the Disease in Hospitalized Patients

Tannaz Abbasi-Dokht et al.

Summary: This study found that the overexpression of T-bet, GATA3, and ROR gamma t, as well as a decrease in FoxP3 expression, were associated with the severity and fatal outcome of COVID-19. Additionally, the expressions of GATA3 and ROR gamma t were positively correlated with elevated CRP and hepatic enzyme concentration. Moreover, they were identified as independent risk factors for the severity and outcome of COVID-19.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy

Mohammad Rafi Khezri et al.

Summary: COVID-19, caused by SARS-CoV-2, has a high mortality rate primarily due to ARDS, cytokine storm, and coagulation complications. Although changes in coagulation factors have been observed in COVID-19 patients, the specific molecular mechanism has not yet been explored. However, the over-activity of the PI3K/AKT signaling pathway in SARS-CoV-2 infection suggests its potential role as a therapeutic target for preventing coagulation complications in COVID-19 patients.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)

Review Pharmacology & Pharmacy

The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19

Maria Sofia Basile et al.

Summary: This review examines the involvement of the PI3K/Akt/mTOR pathway in COVID-19 and discusses the potential use of specific inhibitors of this pathway for treating the disease.

DRUG DISCOVERY TODAY (2022)

Review Immunology

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy

Soheila Fattahi et al.

Summary: COVID-19 is a severe respiratory infection caused by SARS-CoV-2 and is a major global challenge. Although several effective COVID-19 vaccines have been developed, our understanding of specific therapeutic drugs for COVID-19 treatment is still limited. The mTOR pathway plays an important role in viral replication, and mTOR pathway inhibitors may be a potential approach to anti-SARS-CoV-2 therapy.

IMMUNOLOGIC RESEARCH (2022)

Article Medicine, Research & Experimental

Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2

Guoli Shi et al.

Summary: The use of rapalog drugs increases susceptibility to SARS-CoV-2 infection in immunocompromised individuals by promoting virus entry into cells and inhibiting the cell-intrinsic immune response.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Immunology

Immunouniverse of SARS-CoV-2

Dennis Jimenez et al.

Summary: Studying the interaction between SARS-CoV-2 virus and the immune response can help understand the immunopathogenesis and develop potential treatment strategies. Dysregulation of the immune response and hyperinflammation may be one of the main reasons leading to death in COVID-19 patients.

IMMUNOLOGICAL MEDICINE (2022)

Review Biochemistry & Molecular Biology

Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?

Simone Cristina Soares Brandao et al.

Summary: The severe form of COVID-19 is characterized by an abnormal and exacerbated immune response, especially in patients with obesity, diabetes, hypertension, and atherosclerosis. The virus spike protein interacts strongly with TLR4, leading to a cytokine storm and multiple organ failure in some cases.

CYTOKINE & GROWTH FACTOR REVIEWS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling

Fei Li et al.

Summary: The study found that SARS-CoV-2 infection induces autophagy and apoptosis in cells by upregulating intracellular reactive oxygen species (ROS) levels, inhibiting the PI3K/AKT/mTOR pathway, and ultimately triggering inflammatory responses and cell apoptosis. These findings are crucial for understanding the pathogenic inflammation mechanism induced by SARS-CoV-2 infection and developing anti-inflammatory therapies for COVID-19 patients.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Review Medical Laboratory Technology

COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?

Michael J. Ombrello et al.

Summary: Cytokine storms, characterized by hyperinflammation, hemodynamic instability, and multiple organ dysfunction, have been observed in conditions like COVID-19 and rheumatic diseases. Treatment often involves corticosteroids and cytokine inhibitors.

TRANSLATIONAL RESEARCH (2021)

Review Microbiology

Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis

Santhamani Ramasamy et al.

Summary: COVID-19, caused by SARS-CoV-2, is a global pandemic with severe cases manifesting as acute respiratory distress syndrome, often in patients with underlying conditions. Rapid progression of the disease is mainly attributed to hyperinflammation and a lack of interferon response in the early stages.

CLINICAL MICROBIOLOGY REVIEWS (2021)

Article Immunology

IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis

Chiara Cioccarelli et al.

Summary: The study found that the host's inflammatory environment affects the susceptibility of SARS-CoV-2 infection by increasing TMPRSS2 expression, revealing the related molecular mechanisms.

FRONTIERS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition

Peter J. Mullen et al.

Summary: This study revealed that SARS-CoV-2 infection alters host cell metabolism by increasing glucose entry into the TCA cycle and reducing oxidative glutamine metabolism. Additionally, infection with SARS-CoV-2 activates mTORC1, and inhibiting mTORC1 can suppress viral replication in kidney epithelial cells and lung ALI cultures. These findings suggest that targeting mTORC1 could be a potential treatment strategy for COVID-19 patients.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

Chia-Ming Su et al.

Summary: SARS-CoV-2 proteins activate NF-kappa B, leading to the production of proinflammatory cytokines, which may contribute to acute respiratory distress syndrome in COVID-19 patients. Among these proteins, ORF7a plays a significant role in inducing inflammatory cytokines and chemokines expression.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients

Maria Clara Saad Menezes et al.

Summary: This study found that in COVID-19 patients, the severe cases group had lower expression of TLR3 and overexpression of TLR4 when compared to the mild cases group.

SCIENTIFIC REPORTS (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

CO-RADS: Coronavirus Classification Review

Diana Penha et al.

Summary: In mid-January 2021, there were over 95 million diagnosed COVID-19 cases and approximately 2 million deaths globally. Changes in chest computed tomography images of COVID-19 cases requiring hospitalization or intensive care have shown improved sensitivity. The CO-RADS system, developed based on experiences from the first wave of the pandemic, demonstrates good observer reliability and performance in predicting moderate to severe disease.

JOURNAL OF CLINICAL IMAGING SCIENCE (2021)

Review Microbiology

Coronavirus biology and replication: implications for SARS-CoV-2

Philip V'kovski et al.

Summary: This review discusses key aspects of coronavirus biology and their implications for SARS-CoV-2 infections, treatment, and prevention strategies. Understanding virus-host interactions at the molecular level is crucial for developing effective intervention strategies. Summarizing the discoveries of SARS-CoV-2 infection and comparing it with other coronaviruses will support future preparedness and combat strategies.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Time Course of Lung Changes a Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19 )

Feng Pan et al.

RADIOLOGY (2020)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Review Pharmacology & Pharmacy

Molecular immune pathogenesis and diagnosis of COVID-19

Xiaowei Li et al.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)

Review Cell Biology

From causes of aging to death from COVID-19

Mikhail V. Blagosklonny

AGING-US (2020)

Review Biochemistry & Molecular Biology

The molecular virology of coronaviruses

Ella Hartenian et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Medicine, General & Internal

Impact of mTOR gene polymorphisms and gene-tea interaction on susceptibility to tuberculosis

Mian Wang et al.

WORLD JOURNAL OF CLINICAL CASES (2020)

Review Biochemistry & Molecular Biology

Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19

Jan Brabek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients

Lei Cheng et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Review Genetics & Heredity

Predicting Functional Effects of Synonymous Variants: A Systematic Review and Perspectives

Zishuo Zeng et al.

FRONTIERS IN GENETICS (2019)

Article Biochemistry & Molecular Biology

Nuclear factor of activated T cells negatively regulates expression of the tumor necrosis factor receptor-related 2 gene in T cells

Woon-Ki Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2010)

Article Immunology

Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells

Frank Schmitz et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2008)